×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [37]
山东大学 [27]
中国医学科学院 北... [26]
中南大学 [8]
吉林大学白求恩第一医... [5]
武汉大学 [3]
更多...
内容类型
期刊论文 [123]
会议论文 [2]
发表日期
2023 [1]
2022 [2]
2019 [30]
2018 [22]
2017 [21]
2016 [14]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共125条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study
期刊论文
BMC CANCER, 2023, 卷号: 23
作者:
Cao, Fei
;
Shi, Changsheng
;
Zhang, Guofu
;
Luo, Jun
;
Zheng, Jiaping
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2023/11/10
Hepatocellular carcinoma
Atezolizumab
Bevacizumab
Overall survival
Progression-free survival
A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IA1 with LVSI, IA2): study protocol of the LAUNCH 1 trial
期刊论文
BMC CANCER, 2022, 卷号: 22
作者:
Wu, Xin
;
Feng, Hao
;
Gao, Shujun
;
Feng, Hua
;
Diao, Wenjing
收藏
  |  
浏览/下载:36/0
  |  
提交时间:2022/05/16
Cervical cancer
Stage IA1 with LVSI and IA2
Laparoscopic radical hysterectomy
Abdominal radical hysterectomy
Progression-free survival
Overall survival
Prognosis
A multicenter non-inferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stages IB1, IB2, and IIA1): study protocol of the LAUNCH 2 trial
期刊论文
TRIALS, 2022, 卷号: 23
作者:
Wu, Xin
;
Qiu, Ling
;
Lou, Weihua
;
Wang, Xipeng
;
Zhu, Tao
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2022/05/16
Cervical cancer
Stages IB1
IB2
and IIA1
Laparoscopic radical hysterectomy
Abdominal radical hysterectomy
Randomized controlled trials
Progression-free survival
Overall survival
Prognosis
Radiomic signature: A novel magnetic resonance imaging-based prognostic biomarker in patients with skull base chordoma
期刊论文
RADIOTHERAPY AND ONCOLOGY, 2019, 卷号: 141, 页码: 239-246
作者:
Wei, Wei
;
Wang, Ke
;
Liu, Zhenyu
;
Tian, Kaibing
;
Wang, Liang
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2020/03/30
Biomarkers
Magnetic resonance imaging
Prognosis
Progression-free survival
Radiomics
Skull base chordoma
Survival prediction with score model based on clinical characteristics in advanced HCC patients receiving oxaliplatin-containing regimens
期刊论文
NEOPLASMA, 2019, 卷号: 66, 期号: 2
作者:
Dong, Y. B.
;
Qian, L.
;
Zhao, L. L.
;
Zhao, H. J.
;
Cui, J. W.
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2019/12/05
oxaliplatin-containing regimen
HCC patients
progression-free survival (PFS)
overall survival (OS)
score model
Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial
期刊论文
EUROPEAN JOURNAL OF CANCER, 2019, 卷号: 112
作者:
Zhang, Qingyuan
;
Xu, Binghe
;
Funasaka, Setsuo
;
Saito, Kenichi
;
Hiraiwa, Masahide
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2019/12/05
Progression-free survival
Tolerability
Locally recurrent or metastatic breast cancer
Eribulin
Capecitabine plus bevacizumab versus capecitabine in maintenance treatment for untreated characterised KRAS exon 2 wild-type metastatic colorectal cancer: a retrospective analysis in Chinese postmenopausal women
期刊论文
BMC GASTROENTEROLOGY, 2019, 卷号: 19
作者:
Yang, Chen
;
Zhao, Mingdong
;
Zhu, Ying
;
Su, Jinsong
;
Yang, Ruikun
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2019/12/05
Capecitabine
Bevacizumab
Colorectal cancer
Progression-free survival
Overall survival
Elevated serum HER-2 predicts poor prognosis in breast cancer and is correlated to ADAM10 expression
期刊论文
CANCER MEDICINE, 2019, 卷号: 8, 期号: 2
作者:
Zheng, Hui
;
Zhong, Ailing
;
Xie, Suhong
;
Wang, Yanchun
;
Sun, Jiajun
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2019/12/05
ADAM10
breast cancer
HER-2
progression-free survival
Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial
期刊论文
CANCER COMMUNICATIONS, 2019, 卷号: 39
作者:
Kong, Lin
;
Gao, Jing
;
Hu, Jiyi
;
Lu, Rong
;
Yang, Jing
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2019/12/05
Glioblastoma
Anaplastic astrocytoma
Carbon ion radiotherapy
Proton radiotherapy
Temozolomide
Overall survival
Progression-free survival
Toxicity
Serologic immune response
O-6-methylguanine-DNA methyltransferase
Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial
期刊论文
EUROPEAN JOURNAL OF CANCER, 2019, 卷号: 112
作者:
Yuan, Peng
;
Hu, Xichun
;
Sun, Tao
;
Li, Wei
;
Zhang, Qingyuan
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2019/12/05
Progression-free survival
Tolerability
Locally recurrent or metastatic breast cancer
Eribulin
©版权所有 ©2017 CSpace - Powered by
CSpace